Jump to main content
博士論文

成人T細胞白血病(ATL)の治療に向けた新規抗CD70抗体薬物複合体の開発

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

成人T細胞白血病(ATL)の治療に向けた新規抗CD70抗体薬物複合体の開発

Persistent ID (NDL)
info:ndljp/pid/12319694
Material type
博士論文
Author
横田, 璃里
Publisher
International Institute of Anticancer Research
Date granted
2020-09-16
Material Format
Digital
Capacity, size, etc.
-
Degree grantor and degree
鹿児島大学,博士(医学)
View Details

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii ResearchLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

出版タイプ: VoR博士論文全文, 博士論文要旨, 最終試験結果の要旨, 論文審査の要旨Background/Aim: Adult T-cell leukemia (ATL) is a hematological malignancy caused by infection with human T...

Table of Contents

Provided by:国立国会図書館デジタルコレクションLink to Help Page
  • 2024-01-19 再収集

  • 2024-01-19 再収集

  • 2024-01-19 再収集

  • 2024-01-19 再収集

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
横田, 璃里
Author Heading
Publication, Distribution, etc.
Publication Date
2020-09-16
Publication Date (W3CDTF)
2020-09-16
Alternative Title
Novel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL)
Degree Grantor
鹿児島大学
Date Granted
2020-09-16
Date Granted (W3CDTF)
2020-09-16
Dissertation Number
甲総研第576号
Degree Type
博士(医学)
Text Language Code
eng
Target Audience
一般
Note (General)
出版タイプ: VoR
博士論文全文, 博士論文要旨, 最終試験結果の要旨, 論文審査の要旨
Background/Aim: Adult T-cell leukemia (ATL) is a hematological malignancy caused by infection with human T-cell leukemia virus type 1 (HTLV-1). Chemotherapy, antibody therapy, and bone marrow transplantation are used to treat this disease, however, median survival time has not been significantly improved. Our aim was to develop and evaluate a novel antibody-drug conjugate (ADC) with regards to cell cytotoxicity and target specificity. Materials and Methods: In this study, we have constructed a novel ADC, which is composed of an anti-CD70 single chain Fv-Fc antibody conjugated with the anticancer agent emtansine using a novel antibody modification method. Cell cytotoxicity and target specificity were assessed using a cell proliferation assay. Results: The anti-CD70 ADC selectively killed HTLV-1-infected cells and ATL cells without affecting other cells. Conclusion: The anti-CD70 ADC offers some chemotherapeutic potential for the treatment of ATL.RIRI YOKOTA, SHUN HASHIMOTO, IKUKO WATANABE, SATOSHI KISHIMOTO, MASAAKI TOYAMA, MIKA OKAMOTO, MAKOTO YOSHIMITSU, KENJI ISHITSUKA, YUJI ITO and MASANORI BABANovel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL)Anticancer Research 40(8): 4471-4479 (2020)https://doi.org/10.21873/anticanres.14452
Persistent ID (NDL)
info:ndljp/pid/12319694
Collection (Materials For Handicapped People:1)
Collection (particular)
国立国会図書館デジタルコレクション > デジタル化資料 > 博士論文
Acquisition Basis
博士論文(自動収集)
Format (IMT)
PDF
application/pdf
Access Restrictions
国立国会図書館内限定公開
Service for the Digitized Contents Transmission Service
図書館・個人送信対象外
Availability of remote photoduplication service
Data Provider (Database)
国立国会図書館 : 国立国会図書館デジタルコレクション